Toronto-based BlueOcean has taken a number of paths to market, including a modular rapid-growth system for algae production, but lately has focused on developing specialty oils and extended release omega-3 tablets from shrimp, fish, krill and algae oil.
The company advertises the Pure Polar line as the first omega-3 dietary supplements based in part on shrimp oil (the product also contains fish oil). It is available in soft gels in two different concentrations and in extended release tablets. The company believes its shrimp oil product, which is sourced from cold water shrimp fisheries, offers an alternative with its phospholipid structure, its relatively high levels of EPA and DHA per serving (twice as much, the company says, as most krill oil brands per serving) as well as 10 times as much astaxanthin per serving as krill oil.
BlueOcean still has plans for its algae production system, which recently completed a test scale run at the Arizona Center for Algae Technology and Innovation (AzCATI). The test of the modular production mode, which features commercially-available totes as growth vessels and uses the company's CO2 infusion technology to boost growth rates, was successful, company executives said, but the technology is for the moment on the back burner while the company pursues the shrimp oil commercialization.